Table 1

Clinical and virological characteristics of patients
Patient and type of treatment responsea Sex Age HCV Genotype Sample Viral Load log UI/ml Genetic Distance Genetic Distance from baselineb Shannon Entropy
SVR
P05 F 44 1b 6.04 0.006 ± 0.001 0.0096
P35 M 40 1a 6.25 0.005 ± 0.001 0.0074
P40 M 35 1a 6.57 0.004 ± 0.001 0.0042
NR
P08 F 41 1a 5.80 0.008 ± 0.001 0.0126
12wt 4.59 0.009 ± 0.001 0.009 ± 0.001 0.0113
14d 6.18 0.011 ± 0.001 0.014 ± 0.002 0.0157
2m 6.46 0.008 ± 0.001 0.014 ± 0.002 0.0103
6m 6.40 0.007 ± 0.001 0.015 ± 0.002 0.0156
P11 M 72 1b 6.85 0.017 ± 0.001 0.0235
12wt 3.71 0.007 ± 0.001 0.020 ± 0.003 0.0140
14d 6.27 0.005 ± 0.001 0.032 ± 0.004 0.0134
2m 6.73 0.007 ± 0.001 0.034 ± 0.004 0.0132
6m >7.2 0.012 ± 0.002 0.030 ± 0.004 0.0192
P146 M 21 1a 6.92 0.012 ± 0.002 0.0202
12wt 5.54 0.006 ± 0.001 0.014 ± 0.002 0.0097
14d 6.43 0.012 ± 0.001 0.020 ± 0.002 0.0172
2m 6.76 0.012 ± 0.001 0.020 ± 0.002 0.0177
6m 6.96 0.008 ± 0.001 0.017 ± 0.002 0.0119
P44 M 51 1b 6.50 0.016 ± 0.002 0.0139
12wt 6.13 0.019 ± 0.002 0.019 ± 0.002 0.0311
14d 6.24 0.014 ± 0.001 0.023 ± 0.003 0.0206
2m 7.18 0.014 ± 0.001 0.023 ± 0.003 0.0216
6m 6.83 0.014 ± 0.001 0.024 ± 0.003 0.0216
ETR
P03 M 39 1a 5.95 0.011 ± 0.001 0.0131
28d 4.99 0.004 ± 0.001 0.041 ± 0.005 0.0094
2m 5.39 0.003 ± 0.001 0.039 ± 0.005 0.0058
3m 4.74 0.003 ± 0.001 0.039 ± 0.005 0.0055
4m 5.03 0.002 ± 0.001 0.039 ± 0.005 0.0073
5m 5.26 0.001 ± 0.001 0.038 ± 0.005 0.0033
6m 5.08 0.012 ± 0.000 0.038 ± 0.005 0.0038
P37 M 27 1a 6.00 0.005 ± 0.001 0.0137
2m 6.63 0.001 ± 0.001 0.017 ± 0.003 0.0055
3m 6.83 0.002 ± 0.001 0.016 ± 0.003 0.0038
4m 6.30 0.003 ± 0.001 0.016 ± 0.003 0.0066
5m 6.10 0.009 ± 0.001 0.017 ± 0.003 0.0074
6m 6.58 0.014 ± 0.001 0.019 ± 0.003 0.0109
P42 M 56 1b 6.66 0.016 ± 0.002 0.0161
4m 6.24 0.014 ± 0.002 0.030 ± 0.003 0.0162
5m 6.28 0.017 ± 0.002 0.028 ± 0.003 0.0141
6m 6.34 0.022 ± 0.002 0.030 ± 0.003 0.0145
P47 M 47 1a 6.05 0.033 ± 0.002 0.0268
2m 5.67 0.027 ± 0.003 0.039 ± 0.004 0.0466
3m 5.92 0.003 ± 0.002 0.039 ± 0.004 0.0391
4m 5.57 0.011 ± 0.001 0.037 ± 0.004 0.0072
5m 5.87 0.009 ± 0.002 0.038 ± 0.004 0.0197
6m 2.93 0.011 ± 0.002 0.041 ± 0.004 0.0171

aSVR, sustained virological response; NR, non-response; ETR, end-of-treatment response.

●=before treatment; wt=weeks of treatment; d=days after the end of treatment; m=months after the end of treatment.

Jardim et al.

Jardim et al. BMC Infectious Diseases 2013 13:61   doi:10.1186/1471-2334-13-61

Open Data